Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Nicola Maciocia
Observed names:
Maciocia, Nicola Christina,
N. Maciocia,
Nicola C Maciocia,
Nicola C. Maciocia
Institutions:
University College London Hospitals NHS Foundation Trust,
University College London
Observed institutions:
University College Hospital,
University College London Hospitals NHS Foundation Trust,
University College London
ORCID:
0000-0002-3865-3723
Observed ORCID:
0000-0002-3865-3723
OpenAlex ID:
A5052045231
Works
17
Awards
2
Anti-CCR9 chimeric antigen receptor T cells for T-cell acute lymphoblastic leukemia
2022
·
Paul M. Maciocia
, Patrycja A. Wawrzyniecka
, et al.
·
Blood
·
70
PDF
Remission of Follicular Lymphoma after Treatment for Hepatitis C Virus Infection
2016
·
Nicola Maciocia
, Alastair O’Brien
, et al.
·
New England Journal of Medicine
·
35
PDF
CAR T-cell therapies for T-cell malignancies: does cellular immunotherapy represent the best chance of cure?
2024
·
Nicola Maciocia
, Brandon Wade
, et al.
·
Blood Advances
·
32
Real‐world use of pomalidomide and dexamethasone in double refractory multiple myeloma suggests benefit in renal impairment and adverse genetics: a multi‐centre UK experience
2017
·
Nicola Maciocia
, Andrew Melville
, et al.
·
British Journal of Haematology
·
31
PDF
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering myeloma (SMM): a practical guide to management
2016
·
Nicola Maciocia
, Ashutosh Wechalekar
, et al.
·
Hematological Oncology
·
13
Anti-CD21 Chimeric Antigen Receptor (CAR)-T Cells for T Cell Acute Lymphoblastic Leukaemia (T-ALL)
2021
·
Nicola C Maciocia
, Amy Burley
, et al.
·
Blood
·
7
Outcome of Pomalidomide Therapy in Relapsed /Refractory Myeloma: A Uk Multi-Centre Experience
2015
·
N. Maciocia
, F. Sharpley
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
3
A Novel Protein-Based Approach to Generate Allogeneic CAR-T Cells with Simultaneous TCR and MHC Class 1 Downregulation
2022
·
Thaneswari Karpanasamy
, Patrycja Wawrzyniecka
, et al.
·
Blood
·
2
Anti-CCR9 CAR-T Cells for T Acute Lymphoblastic Leukemia
2021
·
Paul M Maciocia
, Patrycja Wawrzyniecka
, et al.
·
Blood
·
2
Real-World Use of Pomalidomide and Dexamethasone in Double Refractory Multiple Myeloma: A Multicentre UK Experience
2016
·
Nicola Maciocia
, Andrew Melville
, et al.
·
Blood
·
2
Preclinical development of anti-CD21 chimeric antigen receptor T cells to treat T cell acute lymphoblastic leukemia
2025
·
Nicola Maciocia
, Malika Hoekx
, et al.
·
Science Translational Medicine
·
1
Outcomes for post‐transplant relapsed acute lymphoblastic leukaemia in the era of novel therapies: A retrospective multicentre UK study
2026
·
Alexandros Rampotas
, Amy A. Kirkwood
, et al.
·
British Journal of Haematology
Late onset pancytopenia post chimeric antigen receptor T cell therapy triggered by a COVID-19 vaccination: a case report
2024
·
Nicola Maciocia
, Dean Spencer
, et al.
·
Frontiers in Hematology
PDF
Pharmacological Modulation of CD21 Antigen Density Enhances Chimeric Antigen Receptor (CAR-T) Cell Function
2022
·
Nicola C Maciocia
, Amy Burley
, et al.
·
Blood
LenD: a study to establish the safety and efficacy of lenalidomide and dexamethasone in patients with relapsed or refractory chronic lymphocytic leukemia
2017
·
Satyen Harish Gohil
, Nicola Maciocia
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
PDF
Show more works
View as search
Works count:
17
Citation count:
200
H-index:
6
I10-index:
5
Year
Topic
Type
